| Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. | lymphoma, |
| results demonstrate that CARD11 is a bona fide oncogene in diffuse large B cell lymphoma | lymphoma, |
| Mutations of CARD11 but not TNFAIP3 may activate the NF-kappaB pathway in primary CNS lymphoma. | lymphoma, |
| The mutations of the oncogene CARD11 may contribute to NF-kappaB activation and thereby play a role in the pathogenesis of Primary CNS lymphoma. | lymphoma, |
| MYD88, CARD11, and CD79B Oncogenic Mutations are Rare Events in the Indian Cohort of De Novo Nodal Diffuse Large B-Cell Lymphoma. | lymphoma, |
| results define molecular determinants that control the production of Lin(Ub)n-Bcl10, an important signaling intermediate in TCR and oncogenic CARD11 signaling. | None |